AI Article Synopsis

  • The herpes simplex viruses, HSV-1 and HSV-2, are common globally and currently have no definitive cure, prompting an analysis of their distinct characteristics based on various factors such as gender, age, and health conditions.
  • A study was conducted using data from the Israeli Central Virology Laboratory between 2011 and 2018, where 9189 samples were diagnosed, alongside a detailed medical data extraction from 287 females with genital infections.
  • Findings revealed that HSV-2 infections were more prevalent in females and that pregnancy is a significant risk factor for reactivation of HSV-2, with a higher incidence found in women diagnosed with HSV-2 compared to those with HSV-1.

Article Abstract

The herpes simplex viruses consist of the strains, HSV-1 and HSV-2, which are prevalent worldwide and lack a definitive cure. We aimed to explore the specific characteristics of HSV 1 and 2 infections, such as differences between gender assigned at birth, age at infection, site of infection, comorbidities, and effect of pregnancy, through a data analysis. Between 2011 and 2018, the Israeli Central Virology Laboratory diagnosed 9189 samples using multiplexed real-time PCR. In addition, we extracted all of the medical data for 287 females hospitalized at the Sheba Medical Center with HSV-1 (161) or HSV-2 (126) genital infections. HSV-2 was almost absent in the orofacial samples from both genders, while in other lesion sites, HSV-2 was significantly more abundant in females than in males ( < 0.05,). HSV-2 was initially detected at puberty. In the hospitalized females' malignancies, both HSV-1 and HSV-2 were found with a non-significant difference. Simultaneously, pregnancies were more common in females who were HSV-2-positive compared with those who were HSV-1-positive (27.8% vs. 12.4%, respectively, < 0.01). Primary infections occur more with HSV-1 than with HSV-2 (15.6% vs. 3.2%, respectively). Our findings demonstrate that genital HSV-2 infection episodes are more frequent during pregnancy, suggesting that pregnancy may serve as a risk factor for HSV-2 reactivation or infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11437484PMC
http://dx.doi.org/10.3390/v16091370DOI Listing

Publication Analysis

Top Keywords

hsv-1 hsv-2
12
hsv-2
10
hsv-2 reactivation
8
infection
5
analysis hsv1/2
4
hsv1/2 infection
4
infection reveals
4
reveals association
4
association hsv-2
4
pregnancy
4

Similar Publications

Background: Approximately 2% of HerpeSelect herpes simples virus type 2 (HSV-2) IgG enzyme immunoassay (screen assay) sera-positive samples do not confirm using an HSV-2 IgG inhibition assay. Of these, roughly 1.33% are confirmed negative, and a small proportion (0.

View Article and Find Full Text PDF

Herpes Simplex virus (HSV) is the cause of genital herpes and no prophylactic treatment is currently available. Replication-incompetent adenoviral vectors are potent inducers of humoral and cellular immune responses in humans. We have designed an adenoviral vector type 35 (Ad35)-based vaccine encoding the HSV-2 major surface antigen gD2 (Ad35.

View Article and Find Full Text PDF

Background And Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir.

Materials And Methods: In our experimental study, was dissolved in DMSO, then diluted in DMEM medium.

View Article and Find Full Text PDF

Background: Richter's transformation (RT) in chronic lymphocytic leukemia (CLL) is associated with poor prognosis and requires prompt modifications in patient care. CLL patients are susceptible to severe infections due to immune dysregulation induced by their malignancy and immunosuppressive therapies.

Case Presentation: We present a case of a 63-year-old man with CLL who previously achieved remission and presented with a right inguinal mass.

View Article and Find Full Text PDF

Estimated global and regional economic burden of genital herpes simplex virus infection among 15-49 year-olds in 2016.

BMC Glob Public Health

July 2024

Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Background: Globally, herpes simplex virus (HSV)-2 and -1 infections contribute to a large disease burden, but their full economic consequences remain unclear. This study aims to estimate the global economic impact of genital HSV-2 and HSV-1 infection and its consequences for people with genital ulcer disease, neonatal herpes, and human immunodeficiency virus (HIV) infection attributable to HSV-2.

Methods: Using a societal perspective, the economic burden was calculated at the country level and presented by World Health Organization (WHO) regions and World-Bank income levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!